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Abstract 
Testicular function is regulated by pituitary hormones and also by paracrine and autocrine factors. 
A number of reports have pointed out the importance of estrogens and progesterone in male re-
productive tract. Recently, we have reported in testicular biopsies from men with Sertoli Cell Only 
Syndrome (SCO) or Hypospermatogenesis (H) with Leydig cell hyperplasia (LCH) an increase in 
the expression of the TGFB1 and its receptors ALK1 and endoglin, which are involved in the prolif-
eration of Leydig cells. The aim of the present work was to analyze the expression of aromatase, 
estrogen and progesterone receptors (ERs, PR) in pathological testicular biopsies with SCO or H 
with and without LCH. The ERs and CYP19 proteins were detected in the Leydig cells from all 
pathological biopsies analyzed. Biopsies with SCO or H with LCH showed an increment in the im-
munostaining of CYP19 and ERs in the Leydig cells respect to biopsies without LCH. The gene ex-
pression of CYP19 was increased in SCO or H biopsies with LCH respect to SCO and H biopsies 
without LCH. PR was localized in Leydig cells and showed a significant increment in biopsies with 
LCH respect from biopsies without LCH. The gene expression of both PRA and PRB was increased 
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in biopsies with LCH respect to biopsies without LCH. In concussion, alterations in the gene ex-
pression of aromatase, ERs, and PR and the likely interactions of these systems with locally pro-
duced factors such as growth factors and cytokines, might lead to Leydig cell proliferation in tes-
ticular pathology. 
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1. Introduction 
Testis exerts two main functions: steroidogenesis and spermatogenesis, which are both finely regulated by en-
docrine, autocrine and paracrine factors. While testosterone is the main steroid produced by testis, estrogens and 
progesterone are also synthesized by male gonads. A number of reports have pointed out the importance of these 
hormones in male reproductive tract [1]-[4]. 
The synthesis of estrogens is catalyzed by aromatase enzyme encoded by CYP19 gene. Although it has been 
reported that aromatase is expressed in germ cells and spermatids [5], Leydig cells have been identified as the 
major site of expression in the testis [3] [6] [7]. Aromatase activity has been shown to be controlled not only by 
LH, cyclic AMP and testosterone, but also by local factors. 
Estrogens exert their effects by the interaction with two different receptors, estrogen receptor α and β (ERal-
pha and ERbeta) [8]. The presence of ERα and β in human testis has been extensively described [5] [7]. Howev-
er, not all studies have agreed in ER localization or expression for the same type of cells. This discrepancy might 
be due either to the occurrence of a number of ERα and β isoforms or to the diverse antibodies employed in the 
studies [9]. In mice testis, ERsα and β modulate the cell proliferation and the steroidogenic process [10].  
The transcriptional responses to estrogenic signalling depend on the concentration and cellular localization of 
ERs. It is now known that ERs function as dimers, and co-expression of ERα and ERβ in a given cell may lead 
to an interaction between these two receptors [11]. In this context, it has been shown that ERα and β can mod-
ulate gene transcription by themselves or, in an indirect way; i.e. ERβ can regulate the ERα action enhancing or 
repressing gene transcription [12] [13].  
The role of progesterone in male reproductive physiology has not yet been established. It has been described 
that progesterone regulates the spermatogenic process [14] [15], and the steroidogenesis in Leydig cells by the 
modulation of Star expression [16]. Progesterone receptors (PR) have been described in spermatozoa of different 
species including adult human testis [17]-[20]. However there are scan information about the action of proge-
sterone on Leydig cell function [21].  
Genomic PR is expressed in two major isoforms, named PRA and PRB, which are the product of two differ-
ent transcriptional start sites [1] [22]. PRA and PRB have, to some extent, different functions. PRA act generally 
as a repressor of PRB, while PRB is a strong activator of target genes [23].  
Azoopermic men (non-obstructive azoospermia) generally present either Sertoli Cell Only Syndrome (SCO) 
or Hypospermatogenesis (H). A group of these patients also have Leydig cell hyperplasia (LCH), which is a be-
nign condition that occur either as multifocal nodules, often bilateral or diffuse [24] [25].  
Recently, Gonzalez et al. have reported the involvement of progesterone in transforming growth factor beta 1 
(TGF-β1) action on TM3 Leydig cell proliferation by inducing the co-receptor endoglin [26]. Furthermore, these 
authors have also demonstrated the expression of TGF-β1 system in testicular biopsies from men with SCO or H 
[27], and have observed that patients with SCO or H who also present LCH showed that the expression of 
TGF-β1 mRNA was higher than SCO or H patients without LCH. They have described the presence of endoglin, 
the co-receptor of ALK-1 (TGFB1 type I receptor), in human Leydig cells and a positive correlation between 
ALK1 and endoglin, suggesting that these proteins might be involved in the hyperplasia/hypertrophy of Leydig 
cells [27].  
The aim of the present study was to analyze the expression profiles of aromatase, ER and PR in pathological 
testicular biopsies with SCO or H with and without LCH. We studied the differential pattern of expression of the 
ERα and ERβ isoforms as well as PRA and PRB isoforms and their involvement on Leydig cell hyperplasia.  
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2. Material and Methods 
2.1. Patients and Testicular Biopsies 
The present study was considered in accordance with the Helsinki Declaration and its last modification in Tokyo 
2004 on human experimentation and was approved by The Ethical Committee of the Durand Hospital (Buenos 
Aires, Argentina) and Ethical Committee of the Instituto de Biología y Medicina Experimental (accredited pro-
vision # 4-DGDOIN-2012 and # 46 to the Central Committee of Ethics in Research, Ministry of Health, Ciudad 
Autónoma de Buenos Aires, Argentina). Informed Consent was obtained from every patients enrolled in the 
study (between the years 2006-2010). 
Nineteen men (27 - 42 years old) presenting idiopathic infertility and non-obstructive azoospermia without 
infection process were included in this study and were assessed and diagnosed by open testicular biopsy. Those 
patients that presented known etiology of infertility, such as genitourinary infections, mumps orchitis, varicocele, 
hypogonadotropic hypogonadism, chromosome anomalies, obstruction or agenesia of seminal ducts were ex-
cluded. 
Azoospermia diagnosis was determined by the analysis of at least two semen samples collected at different 
times. Two replicates of each sample were centrifuged at 3000 × g for 15 min. A detailed physical examination, 
endocrinology profile testing and a testicular biopsy were performed to every patient. Those patients included in 
this study presented normal cariotype. It was considered non-obstructive azoospermia to the presence of defects 
in spermatogenesis in testicular biopsy without evidence of obstruction in the ejaculatory ducts. All the patients 
underwent diagnostic testicular biopsy or sperm retrieval and agreed to supply a piece of testicular tissue (5 mm 
in diameter) for further studies. Tissue was fixed in Bouin’s solution and subjected to histopathological diagno-
sis. The testicular histopathology was categorized according to the most advanced presence of spermatogenesis. 
Two pathologists evaluated all testicular slices. Biopsies were classified either as H or SCO appearance, ac-
cording to McLachlan et al. [28]. The H group included men in which the biopsy specimens contained less than 
17 mature spermatids per tubule [29] [30]. The LCH group presented more than 7 Leydig clusters of more than 
15 cells per 3.14 mm2, in four fields of vision with a 20 × objective [31]. Briefly, biopsies were classified as 
SCO (n = 6), SCO + LCH (n = 2), H (n = 8) and H + LCH (n = 3) according to testicular morphology. Two- 
thirds of the volume of pathological samples was cryopreserved in liquid nitrogen for molecular biology studies. 
2.2. Immunohistochemistry of Human Testicular Tissue 
Bouin’s fixed human testicular biopsies were dehydrated, embedded in paraffin and sectioned at 5 μm. Hema-
toxylin/eosin stain was used to analyze testicular morphology. The sections were deparaffinized with 100% xy-
lene and sequentially rehydrated with 96%, 90%, 80% and 70% ethanol. Endogen peroxydase was blocked with 
3% hydrogen peroxide in absolute methanol for 5 min, washed twice with phosphate-buffered saline (PBS, pH 
7.4) for 5 min each time. The sections were subjected to saponine (0.5%) treatment. Nonspecific binding was 
blocked with normal serum blocking buffer for 20 min at room temperature. The slides were incubated over 
night with the primary antibodies 1:200 diluted rabbit anti-aromatase (ab18995, Abcam, UK) or 1:200 diluted 
rabbit anti-PR (C-19, sc-538, Santa Cruz Biotechnology) at 4˚C ON. Then, samples were incubated with the ap-
propriated 1:200 biotynilated secondary antibody (Vector Labs) and the colour reaction was amplified with kit 
ABC (Vector Labs) and 0.055% w/v 3,3’-diaminobenzidine and 0.1% v/v H2O2 in Tris-HCl. Negative controls 
were processed simultaneously by omitting the primary antibodies and were treated with preimmune serum. 
2.3. Double Immunofluorescence of Human Testicular Tissue 
Dewaxed and rehidrated tissue sections were blocked for 1 h with 15% normal goat serum in PBS and then in-
cubated overnight at 4˚C with primary antibody 1:100 diluted rabbit anti-ERβ (ab3577, Abcam). After three 
rinses in PBS, sections were incubated for 1 h at room temperature with the appropriated 1:300 diluted anti rab-
bit Alexa Fluor (Invitrogen, Carlsbad, CA, USA). After further washing in PBS, sections were incubated over-
night at 4˚C with the primary antibody 1:200 diluted rabbit anti-ERα (MC-20, sc-542, Santa Cruz Biotechnolo-
gy). After three rinses in PBS, sections were incubated in the dark for 1 h at room temperature with 1:300 di-
luted FITC anti-rabbit IgG (H + L) conjugate (Zymed Laboratories, San Francisco, CA, USA). After further 
washing in PBS, slides were mounted with DAKO fluorescence mounting medium (DAKO, USA) and analyzed 
by using a Nikon C1 D-Eclipse Confocal microscope coupled to Ti Eclipse Fluorescence system. Negative con-
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trols were processed simultaneously by omitting the primary antibodies or pre-absorbing the primary antibody 
with synthetic peptides. 
2.4. Image Analysis 
Six sections of each sample were analyzed. Microscope images of aromatase immunoreactivity were captured 
with an optic microscope (BX40, Olympus Optical Corporation, Tokyo, Japan), fitted with a digital camera 
(390CU 3.2 Megapixel CCD Camera, Micrometrics, Spain), while ERα and β and PR immunoreactivity were 
captured with a Nikon C1 D-Eclipse Confocal microscope coupled to Ti Eclipse Fluorescence system. In both 
cases, images were analyzed using Image-Pro Plus software (Image-Pro Plus 6, Media Cybernetics Inc., Be-
thesda, Maryland, USA) and the integrated optical density was measures. All images were taken the same day 
under the same light to avoid external variations. 
2.5. Testicular RNA Isolation and Quantitative Real Time PCR 
Total RNA from human biopsies was extracted with Trizol (Invitrogen) according to the manufacturer’s instruc-
tions. Total RNA (1 ug) was treated with DNAseI (Invitrogen). Reverse transcription reaction was carried out in 
a 20 μl reaction using M-MLV reverse transcriptase (Promega, 200 U/ul) and random hexamers primers (Bio-
dynamics).  
Reverse-transcribed cDNAs were used to amplify mRNA sequences in a Stratagene MPX500 cycler (Stra- 
tagene, USA), using SYBR Green Master Mix Reagent (Applied Biosystems). The forward (F) and reverse 
(R) human primers were: aromatase (NM_000103.3): F: 5’ CTAAATTGCCCCCTCTGAG 3’ and R: 
5’CCACACCAAGAGAAAAAG 3’; PRA-B (NM_001202474.3): F: 5’ ACACCTTGCCTGAAGTTT 3’ and R: 
5’ CTGTCCTTTTCTGGGGGA 3’; PRB (NM_001202474.2): F: 5’ GAGGATAGCTCTGAGTCC 3’ and R: 5’ 
TTTGCCCTTCAGAAGCGG 3’ and GAPDH (NM_002046.4) F: 5’ TGCACCACCAACTGCTTAGC 3’ and R: 
5’GGCATGGACTGTGGTCATGAG 3’. Each primer was used at a concentration of 0.3 μM in each reaction. 
Cycling conditions were as follows: step 1, 10 min at 95˚C; step 2, 15 sec at 95˚C; step 3, 30 sec at 55˚C; step 4, 
30 sec at 60˚C, repeating from step 2 to step 4 40 times. Data from the reaction were collected and analyzed by 
the complementary computer software (Sequence Detection Software, Applied Biosystems, Version 1.3). Melt-
ing curves were run to confirm specificity of the signal. Relative quantification of gene expression was calcu-
lated using standard curves and normalized to GADPH in each sample. 
Quantitative differences in cDNA target between samples were assessed by the mathematical model of Pfaffl [32]. 
An expression ratio was determined for each sample by calculating (Etarget)ΔCt(target)/(EGAPDH)ΔCt(GAPDH), 
where E is the efficiency of the primer set and ΔCt = Ct (normalization cDNA) − Ct (experimental cDNA). The 
amplification efficiency of each primer set was calculated from the slope of a standard amplification curve of 
log (ng cDNA) per reaction vs. Ct value (E = 10 − (1/slope)). Efficiencies of 2 ± 0.1 were considered optimal. 
2.6. Statistical Analysis 
Mean and standard error (SEM) were calculated and Graph Pad Prism Software (version version 5.0 for Win-
dows, GraphPad Software, San Diego, CA, USA) was used for one-way analysis of variance. Newman-Keuls 
test was used when differences between more than two groups were compared. A p-value of less than 0.05 was 
considered significant.  
3. Results 
3.1. Aromatase and ERα and β Expression in Human Testicular Pathologies 
Cytoplasmic aromatase immunostaining (Figure 1, Panel A) was detected in Leydig and Sertoli cells from all 
biopsies studied. The intensity of aromatase immunostaining in Leydig cells was higher in patients with LCH 
compared with patients without LCH (SCO + LCH vs SCO: 5 fold, p < 0.05; H + LCH vs H: 5.6 fold, p < 0.05). 
CYP19 mRNA expression clearly showed a significant increase in testicular biopsies from LCH group (inde-
pendently of whether LCH derived from SCO or H) respect to biopsies without LCH (p < 0.05) (Figure 1, Panel 
B).  
Figure 2 shows the co-localization by immunofluorescence of ERα and ERβ in pathological testicular biop-
sies. ERα was detected mainly in the cytoplasm of Leydig cells in all biopsies studied. ERα nuclear staining  
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(A)                                              (B) 
Figure 1. Immunolocalization of aromatase (A) and CYP19 mRNA expression (B) in human testicular pa-
thologies. (B) Expression of CYP19 mRNA measure by real time PCR. Different letters indicate significant 
differences between groups (p < 0.05). All results are expressed relative to the housekeeping (GADPH) 
gene expression as arbitrary units. Data are plotted as the mean ± SEM. H: Hypospermatogenesis; SCO: 
Sertoli cell-only syndrome; LCH: Leydig Cell Hyperplasia; ST: Seminiferous tubules; LC: Leydig cell. 
 
 
Figure 2. Double color immunofluorescence of estrogen receptor α and β in human testicular pathologies. 
ERα: green color; ERβ: red color. H: Hypospermatogenesis; SCO: Sertoli cell-only syndrome; LCH: 
Leydig cell h yperplasia; ST: Seminiferous tubules; LC: Leydig cell. 
 
was observed in some Sertoli cells and germ cells in biopsies from H or H + LCH patients (Figure 2). The in-
tensity of ERα immunostaining in Leydig cells from biopsies with LCH was higher than in biopsies without 
LCH (SCO + LCH vs SCO: 4 fold, p < 0.05; H + LCH vs H: 5 fold, p < 0.05). 
ERβ was observed mainly in the cytoplasm of Leydig cells in all biopsies analyzed (Figure 2). Nuclear im-
munostanning was detected in some Leydig cells. No immunostaining of ERβ was observed in the seminiferous 
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tubules of biopsies with SCO and LCH + SCO. Low nuclear staining of some Sertoli cells and germ cells was 
observed in biopsies with H and H+LCH (Figure 2). The intensity of ERβ immunostaining in Leydig cells from 
biopsies with LCH was higher than in biopsies without LCH (SCO + LCH vs SCO: 2.3 fold, p < 0.05; H + LCH 
vs H: 7 fold, p < 0.05). 
3.2. Immunostaining of PR and PRA and PRB Gene Expression in Testicular Pathologies 
Total PR was mainly detected in the cytoplasm Leydig cells of all biopsies studied (Figure 3, Panel A). PR was 
detected in the nucleus of some germ cells and with a lesser degree in the cytoplasm of Sertoli cells within the 
seminiferous tubules (Figure 3, Panel A). The intensity of PR immunostaining in Leydig cells was higher in pa-
tients with LCH compared with patients without LCH (SCO + LCH vs SCO: 5.2 fold, p < 0.05; H + LCH vs H: 
3.8 fold, p < 0.05).  
The two isoforms of the PR were measure by real time PCR in pathological testicular biopsies.  
PRA and PRB mRNA expression showed a significant increase in testicular biopsies from LCH group, inde-
pendently of whether LCH derived from SCO or H. (Figure 3, Panel B). 
4. Discussion 
The relevance of estrogens and progesterone in male reproductive system has been acutely documented [1] [4]. 
However, the precise role of these hormones in testicular function and the regulation of their biosynthesis is still 
an issue of research. In this context, aromatase and ERs have been detected not only in testis of normal tissue 
but also in testicular pathologies [8] [33]-[35]. Besides, estrogens have been involved in cell proliferation even 
in Leydig cells [36].  
Aromatase has been detected in somatic cells, germ cells and spermatids both in experimental animal models 
and humans [37]. In the present study, aromatase expression observed by immunohistochemistry was localized 
in both Leydig and Sertoli cells. Particularly, in Leydig cells of biopsies from patients with LCH the immunos-
taining of aromatase was higher than in patients with SCO or H without LCH. Furthermore, these results were 
corroborated by evaluating CYP19 mRNA expression in the biopsies. Lardone et al. [38] have reported that 
CYP19 mRNA and aromatase activity correlates positively with the Leydig cell number in patients with SCO or 
Maturation Arrest. Moreover, it has been shown that transgenic mice that over express the aromatase gene 
(ARO+) present hyperplasia of Leydig cells [39] [40]. 
ERα and β were detected in all biopsies studied. Despite some reports have found no ERα immunostaining in 
human testis [41] [42], others reports have detected both isoforms of ERs in human testicular pathologies in 
agreement with the results presented in this study. These discrepancies might be due to the protocol, antibodies 
used or to the different ER isoforms present in the tissue analyzed [9]. Although ER localization is becoming 
clear, the physiological functions mediated by each receptor are not well defined. It has been long described that 
ERs exert their action as transcriptional factors [43]. 
However, in all testicular biopsies analyzed, ERα presented a cytoplasmic localization in Leydig cells whe-
reas ERβ presented a cytoplasmic and nuclear localization. These results suggest that ERβ would exert its action 
via a classical signalling pathway acting as transcription factor. The cytoplasmic localization of ERα prompts us 
to speculate that this receptor might act in concert with GPR30, the membrane associated ER [44], as was sug-
gested by Albanito et al. [45] who have reported the presence of a complex interplay between GPR30 and ERα. 
In the present study, the immunostaning expression of ERβ was higher than ERα in biopsies which present 
LCH. In agreement with these results, Kauffman et al. [46] have described that in bladder cancer cell lines ERβ 
leads to a significant increase in cell proliferation. In this context, Carpino et al. [47] have observed a high ex-
pression of ERβ in Leydig cell tumors in humans. However, it has been reported that β ERKO mice present 
Leydig cell proliferation and αERKO mice only show hypertrophy of these cells [13]. Moreover, Du Mond et al. 
[48] have reported that estrogens were able to induce the proliferation of TM3 Leydig cells via ERα. 
The total PR protein was mainly localized in the cytoplasm of Leydig cells of all testicular pathological biop-
sies analyzed and with a higher staining observed in the Leydig cells from the LCH groups. Both PRA and PRB 
gene expression were increased in biopsies with SCO and H with LCH respect to biopsies without LCH. This 
suggests that Leydig cells are target sites of progesterone action. Although the intratesticular levels of progeste-
rone are unknown, it is plausible that the progesterone synthesized in Leydig cells might act in an autocrine or 
paracrine manner regulating somatic and spermatogenic cells function. 
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(A) 
 
(B) 
Figure 3. Immunolocalization (A) and mRNA expression (A) of progesterone receptors (PR) in 
human testicular pathologies. (B) Expression of PRA and PRB mRNA measure by real time PCR. 
Different letters indicate significant differences between groups (p < 0.05). All results are ex-
pressed relative to the housekeeping (GADPH) gene expression as arbitrary units. Data are plot-
ted as the mean ± SEM. H: Hypospermatogenesis, SCO: Sertoli cell-only Syndrome, LCH: Ley-
dig cell hyperplasia, ST: Seminiferous tubules, LC: Leydig cell. 
 
Recently, Gonzalez et al. [26] have reported that in mouse Leydig cells progesterone induces endoglin, the 
co-receptor of TGF-β1, leading to cell proliferation. Furthermore, these authors have reported that testicular bi-
opsies with LCH presented an increase in the expression of TGF-β1 and their receptors, particularly ALK1 and 
endoglin, [27]. The effect that TGF-β1 exerts on the proliferation of Leydig cells depends on the cellular context; 
i.e., the presence of factors such as the concentration of this cytokine in the cell environment, and more impor-
tantly, the type of receptors and co receptors present in the Leydig cells [49]. Taking together these observations 
we are prompt to speculate that the presence of PR in human Leydig cells might be involved in the proliferation 
of Leydig cells.  
5. Conclusion 
Estrogens and progesterone are important in the regulation of the male reproductive tract, with clear evidence 
pointing to a direct effect on the function of Leydig cells. Both hormones acting in concert with locally produced 
factors such as growth factors and cytokines could modulate the activity of these cells leading to proliferative 
responses. However, the mechanisms of action of estrogens and progesterone remain to be clarified and these 
data open new considerations in the analysis of the testes in physiological and pathophysiological conditions.  
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